AOD-9604

Research

AOD-9604 (HGH Fragment 176-191)

Aliases
HGH Fragment 176-191, Anti-Obesity Drug 9604
Administration
Subcutaneous injection

Overview

AOD-9604 is a modified fragment of human growth hormone corresponding to its fat-metabolizing region, engineered to isolate growth hormone's lipolytic effect without its impact on growth or blood sugar. Despite promising preclinical data, Phase II human trials failed to demonstrate significant weight loss versus placebo.

Treatments studied

Treatment categories

Obesity / weight management

Designed to isolate growth hormone's fat-burning effect, though human trials have not confirmed a benefit over placebo.